ENDRA Life Sciences Inc. (NDRA) › Capital ExpendituresENDRA Life Sciences Inc. (NDRA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: $7.9K2018: $100.0K2019: $43.6K2020: $75.3K2021: $45.0K2022: $202.6K2023: $33.9K2024: $16.0K2025: $17.3K$17.3K2017Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$17.3K+8.0%2024$16.0K-52.8%2023$33.9K-83.3%2022$202.6K+350.2%2021$45.0K-40.3%2020$75.3K+72.8%2019$43.6K-56.4%2018$100.0K+1171.9%2017$7.9K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share